HCA
TNDM icon

Harbor Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Harbor Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-35,303
Closed -$1.04M – 853
2023
Q4 		$1.04M Buy
35,303
+2,329
+7% +$48.3K 0.2% 125
2023
Q3 		$685K Buy
32,974
+53
+0.2% +$1.46K 0.15% 175
2023
Q2 		$808K Buy
+32,921
New +$1.06M 0.16% 169
2022
Q2 		– Sell
-10,729
Closed -$1.25M – 165
2022
Q1 		$1.25M Sell
10,729
-1,565
-13% -$183K 0.59% 53
2021
Q4 		$1.85M Buy
+12,294
New +$1.66M 0.67% 47

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Harbor Capital Advisors's TNDM Position: Q1 2024 in Review

Harbor Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 35,303 shares — an estimated $1.04M sold.

Harbor Capital Advisors first reported a position in TNDM in Q4 2021 and held it in 5 quarters. The position peaked at $1.85M in Q4 2021. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

  • Harbor Capital Advisors reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
  • Harbor Capital Advisors sold 35,303 Tandem Diabetes Care shares in Q1 2024, an estimated $1.04M.
  • Harbor Capital Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 5 quarters.
  • Harbor Capital Advisors's Tandem Diabetes Care position peaked at $1.85M in Q4 2021.
  • 291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Harbor Capital Advisors's 13F filing for Q1 2024, filed 13 May 2024.